1. Home
  2. BGLC vs NURO Comparison

BGLC vs NURO Comparison

Compare BGLC & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • NURO
  • Stock Information
  • Founded
  • BGLC N/A
  • NURO 1996
  • Country
  • BGLC Malaysia
  • NURO United States
  • Employees
  • BGLC 30
  • NURO N/A
  • Industry
  • BGLC Medical Specialities
  • NURO Medical/Dental Instruments
  • Sector
  • BGLC Health Care
  • NURO Health Care
  • Exchange
  • BGLC Nasdaq
  • NURO Nasdaq
  • Market Cap
  • BGLC 9.2M
  • NURO 7.7M
  • IPO Year
  • BGLC N/A
  • NURO N/A
  • Fundamental
  • Price
  • BGLC $0.51
  • NURO $3.70
  • Analyst Decision
  • BGLC
  • NURO
  • Analyst Count
  • BGLC 0
  • NURO 0
  • Target Price
  • BGLC N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • NURO 7.8K
  • Earning Date
  • BGLC N/A
  • NURO 07-25-2024
  • Dividend Yield
  • BGLC N/A
  • NURO N/A
  • EPS Growth
  • BGLC N/A
  • NURO N/A
  • EPS
  • BGLC N/A
  • NURO N/A
  • Revenue
  • BGLC N/A
  • NURO $5,270,210.00
  • Revenue This Year
  • BGLC N/A
  • NURO N/A
  • Revenue Next Year
  • BGLC N/A
  • NURO N/A
  • P/E Ratio
  • BGLC N/A
  • NURO N/A
  • Revenue Growth
  • BGLC N/A
  • NURO N/A
  • 52 Week Low
  • BGLC N/A
  • NURO $2.70
  • 52 Week High
  • BGLC N/A
  • NURO $7.92
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 54.40
  • NURO 46.75
  • Support Level
  • BGLC $0.46
  • NURO $3.60
  • Resistance Level
  • BGLC $0.48
  • NURO $4.10
  • Average True Range (ATR)
  • BGLC 0.03
  • NURO 0.14
  • MACD
  • BGLC 0.01
  • NURO 0.01
  • Stochastic Oscillator
  • BGLC 80.23
  • NURO 20.00

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: